Delivery Order SPE2DR25D3501-SPE2DR26FM2PU
- Not listed
- The Defense Logistics Agency awarded a $35,191.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The order was competitively awarded with no set-aside designation and is scheduled for completion by January 16, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,484.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $10,187.80 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by February 2, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $4,079.17 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on January 21, 2026, with completion expected by January 22, 2026. This award represents a firm fixed-price transaction issued without set-aside designation, indicating competitive procurement. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent...
- The Defense Logistics Agency awarded a delivery order valued at $2,812.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injections on January 14, 2026. This is a firm fixed-price, non-set-aside delivery order with a completion date of January 15, 2026, to be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $34,651.45 on January 30, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by February 2, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a task order execution under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,644.52 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on December 3, 2025, with completion targeted for December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,971.23 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of January 29, 2026, and performance location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $16,364.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on June 2, 2025. This firm fixed-price delivery order, which is scheduled for completion by June 3, 2025, will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger pharmaceutical supply contract vehicle with the DLA. This...
- The Defense Logistics Agency awarded a $3,214.56 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, and performance will occur at the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal healthcare...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2PUDelivery Order
The Defense Logistics Agency awarded a $37,543.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. The contract, which concludes on January 16, 2026, was competitively awarded without set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order operates under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. That prime contract vehicle provides comprehensive pharmaceutical and medical supply support globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs worldwide. The Zepbound delivery addresses diabetes medication needs within the broader context of the Defense Health Agency and other federal healthcare systems served through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.5k | 1/14/26 |